Heart Failure
Heart Failure
Advertisement
Rob DillardAHA 2024: CardioNerds | November 20, 2024
A study further supports the efficacy of acoramidis in the treatment of people with ATTR-CM.
Read More
Rob DillardAHA 2024: CardioNerds | November 15, 2024
People with amyloidosis have a significantly higher prevalence of atrial fibrillation.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
An AI model for detecting ATTR-CA yields solid diagnostic results.
Rob DillardAHA 2024: CardioNerds | November 18, 2024
On average, the readability of patient educational materials on cardiac amyloidosis fails to meet NIH standards.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
A deep-learning model is able to detect ATTR-CM with robust efficacy.
CardioNerdsCardioNerds | November 14, 2024
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Artificial intelligence-enhanced ECG models can effectively detect cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Individuals with transthyretin amyloid cardiomyopathy who have clonal hematopoiesis have an increased risk of mortality.
Jordana JampelHeart Failure | November 4, 2024
CLEAR SYNERGY is the largest trial to date on colchicine treatment in myocardial infarction.
Rob DillardCardioNerds | November 4, 2024
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
Rob DillardInterventional Cardiology | October 16, 2024
Researchers have developed a novel blood test that can diagnose a heart attack within minutes.
Rob DillardCOVID-19 | October 9, 2024
COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.
Rob DillardHeart Failure | October 4, 2024
BridgeBio Pharma announced this week outcomes from the ATTRibute-CM study will be shared at AHA 2024.
Rob DillardHeart Failure | September 30, 2024
Bridge Bio Pharma presented results from a post-hoc analysis which demonstrated the efficacy of acoramidis in ATTR-CM.
Amit Goyal, MDCardioNerds | September 26, 2024
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
Amit Goyal, MDCardioNerds | September 25, 2024
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
CardioNerdsCardioNerds | September 26, 2024
The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy.
Rob DillardHeart Failure | September 26, 2024
An AI-enabled stethoscope can help physicians identify twice as many cases of heart failure compared to usual obstetric care.
Rob DillardESC Congress 2024 | August 30, 2024
People that 'catch up' on their sleep during the weekends have a considerably lower risk of heart disease.
Rob DillardInterventional Cardiology | August 21, 2024
The risk of early heart failure following heart transplantation is lower with so-called "heart-in-a-box" storage.
Advertisement
Advertisement
Advertisement
Latest News

November 20, 2024